Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal leydig cells

76Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Background: Perfluorooctane sulfonate (PFOS) is a synthetic material that has been widely used in industrial applications for decades. Exposure to PFOS has been associated with decreased adult testosterone level, and Leydig cell impairment during the time of adulthood. However, little is known about PFOS effects in utero on fetal Leydig cells (FLC). Methods and Results: The present study investigated effects of PFOS on FLC function. Pregnant Sprague Dawley female rats received vehicle (0.05% Tween20) or PFOS (5, 20 mg/kg) by oral gavage from gestational day (GD) 11-19. At GD20, testosterone (T) production, FLC numbers and ultrastructure, testicular gene and protein expression levels were examined. The results indicate that exposures to PFOS have affected FLC function as evidenced by decreased T production, impaired FLC, reduced FLC number, and decreased steroidogenic capacity and cholesterol level in utero. Conclusion: The present study shows that PFOS is an endocrine disruptor of male reproductive system as it causes reduction of T production and impairment of rat fetal Leydig cells. © 2014 Zhao et al.

Cite

CITATION STYLE

APA

Zhao, B., Li, L., Liu, J., Li, H., Zhang, C., Han, P., … Chu, Y. (2014). Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal leydig cells. PLoS ONE, 9(1). https://doi.org/10.1371/journal.pone.0078888

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free